Edward M Schaeffer MD, PhDAssociate Professor of Urology, Oncology and Pathology; Director International Urology; Co-Director Prostate Cancer Multi-Disciplinary Clinic, The Johns Hopkins University School of Medicine, Baltimore, Maryland
Edward M (Ted) Schaeffer, MD, PhD, Associate Professor of Urology, Oncology and Pathology, was born in Palo Alto California and graduated from University of Chicago with undergraduate, graduate and medical degrees. He joined the faculty after completing his general surgery and urology training at Johns Hopkins.
Dr. Schaeffer has an active clinical practice in Urologic Oncology specializing in Prostate, Bladder and Kidney cancer. He has expertise in open, laparoscopic and robot treatment of these malignancies. As an active member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr. Schaeffer participates in multidisciplinary approaches to the treatment of genitourinary cancers.
Dr. Schaeffer is also a fully trained scientist and an expert in prostate development and prostate carcinogenesis. His laboratory currently investigates novel pathways of prostate and bladder carcinogenesis through utilization of experimental embryology and systems of epithelial injury repair.
Dr. Schaeffer's accomplishments in both medicine and science have recently been acknowledged with several awards including the AUA/Astellas "Rising Star" award and a Howard Hughes Clinician-Scientist Early Careers Award.
Recent Contributions to PracticeUpdate:
- Use of mpMRI and Fusion-Guided Biopsies to Select and Follow African American Men on Active Surveillance
- Outcomes of Radical Prostatectomy for High-Risk Prostate Cancer in the UK
- Impact of Length of Time From Diagnosis to Surgery for Unfavorable Intermediate- to Very High–Risk Localized Prostate Cancer
- Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy
- Comparison of Four Preoperative Nomograms for Prediction of Lymph Node Invasion Before Radical Prostatectomy
- Predictors of Infectious Complications After Targeted Prophylaxis for Prostate Needle Biopsy
- Physicians' Perceptions of Factors Influencing Treatment Decisions for Low-Risk Prostate Cancer
- Ertapenem Prophylaxis for TRUS-Guided Prostate Biopsy Is Not Selective Carbapenem-Resistant Organisms
- Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative UTIs After Urologic Surgical Procedures?
- Similar Outcomes With Two Prostate Cancer Active Surveillance Strategies